Ankylosing Spondylitis Market Introduction and Overview
According to SPER market research, ‘Ankylosing Spondylitis Market Size- By Drug Class, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2034’ state that the Global Ankylosing Spondylitis Market is predicted to reach 11.75 billion by 2034 with a CAGR of 6.66%.
Ankylosing spondylitis (AS) is a chronic inflammatory illness mostly affecting the spine and sacroiliac joints, causing pain, stiffness, and progressive vertebral fusion. It is characterized as axial spondyloarthritis and is often related with the HLA-B27 genetic marker. AS primarily affects young adults, with symptoms beginning in late adolescence or early adulthood. Over time, inflammation can cause vertebrae to fuse, resulting in diminished spinal flexibility and a stooped posture.
Restraints: One of the most significant obstacles is the high expense of biologic medicines such as TNF inhibitors and IL-17 inhibitors, which makes treatment inaccessible for many patients, particularly those in low- and middle-income countries. Furthermore, delayed identification due to the non-specific early symptoms of AS frequently results in disease progression before correct therapy can begin, reducing the efficacy of existing medicines.
Scope of the Report:
Report Metric Details
Market size available for years 2021-2034
Base year considered 2024
Forecast period 2025-2034
Segments covered By Drug Class, By Distribution Channel.
Regions covered
North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
Companies Covered
AbbiVie, Inc, Amgen, Inc, Eli Lilly and Company, Izana Biosciences, Johnson and Johnson Services, Inc, Merck and Co., Inc, Novartis AG, Pfizer, Inc, UCB, Inc, Zydus Lifescience Ltd. and others.
Ankylosing Spondylitis Market Segmentation:
By Drug Class: Based on the Drug Class, Global Ankylosing Spondylitis Market is segmented as; Non-Steroidal Anti-Inflammatory Drug (NSAID), TNF Inhibitors.
By Distribution Channel: Based on the Distribution Channel, Global Ankylosing Spondylitis Market is segmented as; Hospital Pharmacy, Retail Pharmacy.
By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook